Article Text

Update on the biology and management of renal cell carcinoma
  1. Janice P Dutcher
  1. Correspondence to Dr Janice P Dutcher, Cancer Research Foundation, Chappaqua, NY 10514, USA; jpd4401{at}


Renal cell cancer (RCC) (epithelial carcinoma of the kidney) represents 2%–4% of newly diagnosed adult tumors. Over the past 2 decades, RCC has been better characterized clinically and molecularly. It is a heterogeneous disease, with multiple subtypes, each with characteristic histology, genetics, molecular profiles, and biologic behavior. Tremendous heterogeneity has been identified with many distinct subtypes characterized. There are clinical questions to be addressed at every stage of this disease, and new targets being identified for therapeutic development. The unique characteristics of the clinical presentations of RCC have led to both questions and opportunities for improvement in management. Advances in targeted drug development and understanding of immunologic control of RCC are leading to a number of new clinical trials and regimens for advanced disease, with the goal of achieving long-term disease-free survival, as has been achieved in a proportion of such patients historically. RCC management is a promising area of ongoing clinical investigation.

  • kidney diseases

Statistics from


  • Contributors JPD designed and researched and wrote this manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests JPD is a consultant for Prometheus Laboratories; a member of data safety and monitoring committees for BMS, Eisai, Tracon, Merck, Amgen, Iovance, and PrECOG. JPD is a medical oncology cochair of the Renal Task Force, CTEP, NCI.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.